[go: up one dir, main page]

MX2020000009A - Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos. - Google Patents

Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos.

Info

Publication number
MX2020000009A
MX2020000009A MX2020000009A MX2020000009A MX2020000009A MX 2020000009 A MX2020000009 A MX 2020000009A MX 2020000009 A MX2020000009 A MX 2020000009A MX 2020000009 A MX2020000009 A MX 2020000009A MX 2020000009 A MX2020000009 A MX 2020000009A
Authority
MX
Mexico
Prior art keywords
secnidazole
gelatin capsule
soft gelatin
novel
capsule formulations
Prior art date
Application number
MX2020000009A
Other languages
English (en)
Inventor
Irena Mcguffy
Robert Jacks
Linus Fonkwe
Original Assignee
Lupin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Inc filed Critical Lupin Inc
Publication of MX2020000009A publication Critical patent/MX2020000009A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las modalidades descritas en el presente documento se dirigen a nuevas formulaciones en cápsulas de gelatina para administración intravaginal que comprenden compuestos de secnidazol y los métodos y los usos de estas composiciones farmacéuticas en el tratamiento de vaginosis bacteriana.
MX2020000009A 2017-07-07 2018-07-03 Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos. MX2020000009A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762529991P 2017-07-07 2017-07-07
PCT/US2018/040743 WO2019010195A1 (en) 2017-07-07 2018-07-03 NOVEL SECNIDAZOLE MOLLE GELATIN CAPSULE FORMULATIONS AND USES THEREOF

Publications (1)

Publication Number Publication Date
MX2020000009A true MX2020000009A (es) 2020-08-06

Family

ID=64904363

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000009A MX2020000009A (es) 2017-07-07 2018-07-03 Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos.

Country Status (9)

Country Link
US (1) US20190008784A1 (es)
EP (1) EP3648749A4 (es)
JP (1) JP2020526512A (es)
KR (1) KR20200027519A (es)
AU (1) AU2018298043A1 (es)
CA (1) CA3068950A1 (es)
MX (1) MX2020000009A (es)
WO (1) WO2019010195A1 (es)
ZA (1) ZA202000490B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
US20210015755A1 (en) * 2019-07-17 2021-01-21 Lupin Inc. Secnidazole soft gelatin capsule and methods and uses thereof
CA3193245A1 (en) * 2020-09-22 2022-03-31 Helen S. PENTIKIS Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
US10335390B2 (en) * 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
CN104257626A (zh) * 2014-10-14 2015-01-07 武汉科技大学 一种塞克硝唑软胶囊及其制备方法
WO2016196653A1 (en) * 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2017149392A1 (en) * 2016-03-04 2017-09-08 Sharon Anavi-Goffer Self-emulsifying compositions of cb2 receptor modulators

Also Published As

Publication number Publication date
CA3068950A1 (en) 2019-01-10
ZA202000490B (en) 2022-07-27
KR20200027519A (ko) 2020-03-12
AU2018298043A1 (en) 2020-02-20
US20190008784A1 (en) 2019-01-10
WO2019010195A1 (en) 2019-01-10
JP2020526512A (ja) 2020-08-31
EP3648749A4 (en) 2020-07-15
EP3648749A1 (en) 2020-05-13

Similar Documents

Publication Publication Date Title
PH12020550341A1 (en) Niraparib formulations
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
MX2018002301A (es) Composiciones de glucano y usos de las mismas.
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
MX2015017964A (es) Inhibidores de bromodominio.
MY188139A (en) Sodium channel modulators for the treatment of pain
MX361590B (es) Suministro topico de composiciones para la piel que tienen ph bajo.
PH12019502782A1 (en) Fixed dose formulations
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
IN2013MU03583A (es)
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
MX2019004580A (es) Formulaciones farmaceuticas y metodos para prepararlas.
PH12020550942A1 (en) Antimicrobial peptides and methods of using same
MX2021005245A (es) Composiciones de oligosacaridos y metodos de uso de las mismas.
MX2021003643A (es) Derivados de terpenoides y usos de los mismos.
MX2020000009A (es) Nuevas formulaciones en capsulas de gelatina blandas de secnidazol y sus usos.
MX2022013450A (es) Formulaciones farmaceuticas.
MX2020013389A (es) Composiciones de terlipresina y usos de las mismas.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX391191B (es) Composiciones de liberación extendida de onapristona y métodos.
PH12018502139A1 (en) Phosphaplatin liquid formulations
PH12021552462A1 (en) Vaginal tablet formulation
MX393915B (es) Nuevas formulaciones orales de belinostat.
PH12019500024A1 (en) Pharmaceutical compositions